Author/Editor     Pregelj, Peter
Title     Sodelovanje bolnikov s shizofrenijo pri zdravljenju z antipsihotiki
Translated title     Adherence to antipsychotic medication in schizophrenia patients
Type     članek
Source     Zdrav Vestn
Vol. and No.     Letnik 78, št. 1
Publication year     2009
Volume     str. 33-6
Language     slo
Abstract     Background Antipsychotic medications have been reduced severity and duration of acute psychotic episode and the number of recurrent psychotic episodes among persons with schizophrenia by long-term use of this medication. However, poor adherence to antipsychotic medication in schizophrenia has been associated with increased rate of rehospitalisation and relapse. The nonadherence to antipsychotic medication is often underestimated. Good adherence to antipsychotic medication is one of the corner stones of long remissions. Conclusions On the basis of different studies it could be concluded that around one half of the schizophrenia patients have poor adherence to antipsychotic medication. To increase adherence to antipsychotic medication good therapeutic alliance should be established with positive emotions, bilateral communication and patient involvement in decision making. The adherence to the antipsychotic medication could be improved with the agreement about psychopharmacotherapy. Antipsychotic therapy should be understandable, tolerable and acceptable for the patient.
Summary     Izhodišča Dolgotrajna uporaba antipsihotikov pri zdravljenju shizofrenije je privedla do zmanjšanja intenzivnosti in trajanja akutnih psihotičnih epizod ter števila njihovih ponovitev. Slabo sodelovanje bolnikov s shizofrenijo pri jemanju antipsihotikov je povezano s pogostejšimi relapsi in pogostejšim zdravljenjem v bolnišnici. Nesodelovanje bolnikov pri zdravljenju z antipsihotiki se pogosto podcenjuje. Dobro sodelovanje bolnikov pri zdravljenju z antipsihotiki je eden ključnih predpogojev za doseganje dolgotrajnih remisij. Zaključki Po podatkih različnih raziskav je mogoče sklepati, da pri zdravljenju z antipsihotiki ne sodeluje skoraj polovica bolnikov. Za povečanje sodelovanja pri zdravljenju je pomemben dober terapevtski odnos s pozitivnimi čustvi, komunikacijo ter soudeležbo bolnika. Z dogovorom o izbiri ustreznega antipsihotičnega zdravljenja, ki je bolniku razumljiva, dobro prenosljiva in enostavna za prejemanje, je mogoče sodelovanje izboljšati.
Descriptors     SCHIZOPHRENIA
ANTIPSYCHOTIC AGENTS
LONG-TERM CARE
PATIENT COMPLIANCE